Author:
Hu Jinwei,Yuan Isabella J.,Mirshahidi Saied,Simental Alfred,Lee Steve C.,Yuan Xiangpeng
Abstract
Thyroid carcinoma consists a group of phenotypically heterogeneous cancers. Recent advances in biological technologies have been advancing the delineation of genetic, epigenetic, and non-genetic factors that contribute to the heterogeneities of these cancers. In this review article, we discuss new findings that are greatly improving the understanding of thyroid cancer biology and facilitating the identification of novel targets for therapeutic intervention. We review the phenotypic features of different subtypes of thyroid cancers and their underlying biology. We discuss recent discoveries in thyroid cancer heterogeneities and the critical mechanisms contributing to the heterogeneity with emphases on genetic and epigenetic factors, cancer stemness traits, and tumor microenvironments. We also discuss the potential relevance of the intratumor heterogeneity in understanding therapeutic resistance and how new findings in tumor biology can facilitate designing novel targeting therapies for thyroid cancer.
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference218 articles.
1. The American Cancer Societyhttps://www.cancer.org/cancer/thyroid-cancer/about/key-statistics.html
2. Surveillance Epidemiology and End Results (SEER) Program,2006
3. Thyroid carcinoma: Epidemiology, histology, and diagnosis;Shah;Clin. Adv. Hematol. Oncol.,2015
4. Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013
5. Anaplastic thyroid carcinoma: A therapeutic challenge
Cited by
54 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献